PRESS RELEASE published on 11/01/2023 at 15:02, 2 years 8 months ago Reset Pharma Receives Notice of Safe to Proceed from FDA for Investigational New Drug (IND) Application for Oral Psilocybin RSTP1000
PRESS RELEASE published on 01/05/2023 at 14:00, 3 years 6 months ago Reset Pharmaceuticals Appoints Innes Meldrum as President and Chief Executive Officer
Published on 07/22/2026 at 15:00, 6 hours 1 minute ago Karbon-X Secures Technical Advisory Engagement for Nature-Based Carbon Project in Libya
Published on 07/22/2026 at 15:00, 6 hours 1 minute ago Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF) Due to Microvillus Inclusion Disease (MVID)
Published on 07/22/2026 at 14:35, 6 hours 26 minutes ago Wi2Wi Reports Significant Manufacturing Yield Improvement in Q2 2026
Published on 07/22/2026 at 14:30, 6 hours 31 minutes ago As Ebola Death Toll Surpasses 930 Within Two Months, NanoViricides Has Applied to the DR Congo Regulatory Agency for Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola
Published on 07/22/2026 at 20:44, 17 minutes ago EQS-Adhoc: CHAPTERS Group AG: Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on July 22, 2026
Published on 07/22/2026 at 20:08, 53 minutes ago EQS-Adhoc: FUCHS SE: Preliminary results for the first half of the year ahead of expectations and increase in the EBIT forecast for 2026
Published on 07/22/2026 at 19:35, 1 hour 26 minutes ago Stabilus SE: Invitation to a web conference on Q3 FY2026 results on August 3, 2026
Published on 07/22/2026 at 19:29, 1 hour 31 minutes ago EQS-Adhoc: Stabilus SE: Profit from operating activities and profit for the period significantly higher, adjusted FCF lower than in Q3 of the prior year; full-year forecast specified within the original ranges
Published on 07/22/2026 at 18:19, 2 hours 42 minutes ago Covivio successfully places €500 million of 7-year European Green Bonds
Published on 07/22/2026 at 17:45, 3 hours 16 minutes ago Groupe CRIT : 2026 first half revenue: €1.67 billion (+2.3% on an organic basis).
Published on 07/22/2026 at 17:40, 3 hours 21 minutes ago Report on share repurchases from 15 to 21 July 2026
Published on 07/22/2026 at 08:03, 12 hours 58 minutes ago Availability of the 2026 Interim Results Report
Published on 07/22/2026 at 08:00, 13 hours 1 minute ago Neoen launches construction of Narrogin Wind Farm in Western Australia after signing PPA with Synergy
